| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Akiko Iwasaki—aiming at making vaccines better
|
Kirby, Tony
|
|
|
21 |
8 |
p. 1082
|
artikel
|
| 2 |
A kikosewin approach to motherhood
|
De Ambrogi, Marco
|
|
|
21 |
8 |
p. 1085
|
artikel
|
| 3 |
An eventful 20 years
|
The Lancet Infectious Diseases,
|
|
|
21 |
8 |
p. 1051
|
artikel
|
| 4 |
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
|
Uwimana, Aline
|
|
|
21 |
8 |
p. 1120-1128
|
artikel
|
| 5 |
Benznidazole in Chagas disease study: do the data justify progression to phase 3?
|
Alteri, Enrica
|
|
|
21 |
8 |
p. 1066-1067
|
artikel
|
| 6 |
Benznidazole in Chagas disease study: do the data justify progression to phase 3? – Authors’ reply
|
Torrico, Faustino
|
|
|
21 |
8 |
p. 1067
|
artikel
|
| 7 |
Biodefence research two decades on: worth the investment?
|
Long, Carrie M
|
|
|
21 |
8 |
p. e222-e233
|
artikel
|
| 8 |
Cameroon's bold response to the COVID-19 pandemic during the first and second waves
|
Esso, Linda
|
|
|
21 |
8 |
p. 1064-1065
|
artikel
|
| 9 |
Can the USA return to pre-COVID-19 normal by July 4?
|
Moghadas, Seyed M
|
|
|
21 |
8 |
p. 1073-1074
|
artikel
|
| 10 |
Clinical interventions for tungiasis (sand flea disease): a systematic review
|
Abrha, Solomon
|
|
|
21 |
8 |
p. e234-e245
|
artikel
|
| 11 |
Correction to Lancet Infect Dis 2021; 21: 1129–40
|
|
|
|
21 |
8 |
p. e208
|
artikel
|
| 12 |
Correction to Lancet Infect Dis 2021; 21: 616
|
|
|
|
21 |
8 |
p. e208
|
artikel
|
| 13 |
Correction to Lancet Infect Dis 2021; 21: 629–36
|
|
|
|
21 |
8 |
p. e208
|
artikel
|
| 14 |
Correction to Lancet Infect Dis 2021; published online June 23. https://doi.org/10.1016/ S1473-3099(21)00330-3
|
|
|
|
21 |
8 |
p. e208
|
artikel
|
| 15 |
Correction to Lancet Infect Dis 2020; published online May 31. https://doi.org/10.1016/S1473-3099(20)30873-2
|
|
|
|
21 |
8 |
p. e208
|
artikel
|
| 16 |
COVID-19 and SOS tweets in India
|
Jena, Anuraag
|
|
|
21 |
8 |
p. 1072-1073
|
artikel
|
| 17 |
Detective doctor decodes AIDS mystery
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
8 |
p. 1088
|
artikel
|
| 18 |
Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial
|
Hofmann, Daniela
|
|
|
21 |
8 |
p. 1151-1160
|
artikel
|
| 19 |
Elizabeth Ashley—leading research at malaria's frontline
|
Kenyon, Georgina
|
|
|
21 |
8 |
p. 1083
|
artikel
|
| 20 |
Entering a labyrinth of COVID-19 stories
|
Ranscombe, Peter
|
|
|
21 |
8 |
p. 1084
|
artikel
|
| 21 |
Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis
|
Mashunye, Thandiwe R
|
|
|
21 |
8 |
p. 1161-1174
|
artikel
|
| 22 |
Fractional-dose IPV in polio eradication
|
Macklin, Grace R
|
|
|
21 |
8 |
p. 1061-1062
|
artikel
|
| 23 |
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|
Hoenigl, Martin
|
|
|
21 |
8 |
p. e246-e257
|
artikel
|
| 24 |
Hand hygiene in health care: 20 years of ongoing advances and perspectives
|
Lotfinejad, Nasim
|
|
|
21 |
8 |
p. e209-e221
|
artikel
|
| 25 |
Has artemisinin resistance emerged in Africa?
|
Rosenthal, Philip J
|
|
|
21 |
8 |
p. 1056-1057
|
artikel
|
| 26 |
Impact of COVID-19 on migrants and refugees
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
8 |
p. 1076-1077
|
artikel
|
| 27 |
Infected blood inquiry in the UK
|
Burki, Talha
|
|
|
21 |
8 |
p. 1078-1079
|
artikel
|
| 28 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
21 |
8 |
p. 1079
|
artikel
|
| 29 |
Isolated pelvic bone involvement as a presentation of alveolar echinococcosis
|
Cambier, Audrey
|
|
|
21 |
8 |
p. 1192
|
artikel
|
| 30 |
Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2?
|
Iversen, Patrick L
|
|
|
21 |
8 |
p. 1054-1055
|
artikel
|
| 31 |
Long COVID has exposed medicine's blind-spot
|
Burke, Matthew J
|
|
|
21 |
8 |
p. 1062-1064
|
artikel
|
| 32 |
Measuring health-care delays among privately insured patients with tuberculosis in the USA: an observational cohort study
|
El Halabi, Jessica
|
|
|
21 |
8 |
p. 1175-1183
|
artikel
|
| 33 |
Moxidectin: an ally to ivermectin for treating Strongyloides stercoralis?
|
Bisoffi, Zeno
|
|
|
21 |
8 |
p. 1060-1061
|
artikel
|
| 34 |
Nabil Aziz Awad Alla
|
Bagcchi, Sanjeet
|
|
|
21 |
8 |
p. 1081
|
artikel
|
| 35 |
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
|
Torrico, Faustino
|
|
|
21 |
8 |
p. 1129-1140
|
artikel
|
| 36 |
New treatment regimens for Chagas disease: light at the end of the tunnel?
|
Morillo, Carlos A
|
|
|
21 |
8 |
p. 1057-1058
|
artikel
|
| 37 |
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study
|
Drozd, Michael
|
|
|
21 |
8 |
p. 1184-1191
|
artikel
|
| 38 |
Old politics in pandemic management
|
MacDougal, Heather
|
|
|
21 |
8 |
p. 1087
|
artikel
|
| 39 |
Parasitological cure in children infected with Trypanosoma cruzi
|
Leony, Leonardo M
|
|
|
21 |
8 |
p. 1058-1059
|
artikel
|
| 40 |
Pathogen-free diagnosis of tuberculosis
|
Heyckendorf, Jan
|
|
|
21 |
8 |
p. 1066
|
artikel
|
| 41 |
Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study
|
Boum, Yap
|
|
|
21 |
8 |
p. 1089-1096
|
artikel
|
| 42 |
Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study
|
Jurado Medina, Laura
|
|
|
21 |
8 |
p. 1141-1150
|
artikel
|
| 43 |
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
|
Jentsch, Peter C
|
|
|
21 |
8 |
p. 1097-1106
|
artikel
|
| 44 |
Research in brief
|
Devi, Sharmila
|
|
|
21 |
8 |
p. 1080
|
artikel
|
| 45 |
Rolling out COVID-19 antigen rapid diagnostic tests: the time is now
|
Peeling, Rosanna W
|
|
|
21 |
8 |
p. 1052-1053
|
artikel
|
| 46 |
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
|
Yang, Shilong
|
|
|
21 |
8 |
p. 1107-1119
|
artikel
|
| 47 |
SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
|
Ramanathan, Muthukumar
|
|
|
21 |
8 |
p. 1070
|
artikel
|
| 48 |
SARS-CoV-2 rapid antigen detection tests
|
Fouzas, Sotirios
|
|
|
21 |
8 |
p. 1068-1069
|
artikel
|
| 49 |
SARS-CoV-2 rapid antigen detection tests
|
Weitzel, Thomas
|
|
|
21 |
8 |
p. 1067-1068
|
artikel
|
| 50 |
SARS-CoV-2 rapid antigen detection tests – Authors' reply
|
Peeling, Rosanna W
|
|
|
21 |
8 |
p. 1069-1070
|
artikel
|
| 51 |
Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
|
Chen, Yuxin
|
|
|
21 |
8 |
p. 1071-1072
|
artikel
|
| 52 |
The interplay between COVID-19 restrictions and vaccination
|
Wells, Chad R
|
|
|
21 |
8 |
p. 1053-1054
|
artikel
|
| 53 |
Vaccine hesitancy in the COVID-19 era
|
Adhikari, Bipin
|
|
|
21 |
8 |
p. 1086
|
artikel
|
| 54 |
What chikungunya teaches us about COVID-19
|
Simon, Fabrice
|
|
|
21 |
8 |
p. 1070-1071
|
artikel
|
| 55 |
World Microbe Forum 2021
|
Mushtaq, Ammara
|
|
|
21 |
8 |
p. 1075
|
artikel
|
Tijdschrift beschrijving